TWD 76.2
(-1.3%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 1.12 Billion TWD | 3.12% |
2022 | 1.09 Billion TWD | 31.55% |
2021 | 831.89 Million TWD | -9.99% |
2020 | 924.17 Million TWD | 2.68% |
2019 | 900.08 Million TWD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | 261.71 Million TWD | -6.79% |
2024 Q1 | 280.77 Million TWD | 37.1% |
2023 FY | 1.12 Billion TWD | 3.12% |
2023 Q3 | 376.33 Million TWD | 21.91% |
2023 Q4 | 204.79 Million TWD | -45.58% |
2023 Q1 | 238.68 Million TWD | -2.45% |
2023 Q2 | 308.69 Million TWD | 29.33% |
2022 Q4 | 244.67 Million TWD | 0.0% |
2022 FY | 1.09 Billion TWD | 31.55% |
2021 FY | 831.89 Million TWD | -9.99% |
2020 FY | 924.17 Million TWD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Allied Biotech Corporation | 97.41 Million TWD | -1058.491% |
GeneFerm Biotechnology Co., Ltd. | 124.62 Million TWD | -805.553% |
Easywell Biomedicals, Inc. | -144.81 Million TWD | 879.26% |
Synmosa Biopharma Corporation | 594.83 Million TWD | -89.719% |
Orient EuroPharma Co., Ltd. | 143.94 Million TWD | -683.997% |
Center Laboratories, Inc. | -995.42 Million TWD | 213.37% |
Tien Liang BioTech Co., Ltd. | 17.73 Million TWD | -6264.251% |
Orient Pharma Co., Ltd. | 22.28 Million TWD | -4963.303% |
InnoPharmax Inc. | -70.83 Million TWD | 1693.242% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 79.7 Million TWD | -1315.946% |
Excelsior Biopharma Inc. | -91.01 Million TWD | 1339.97% |
DV Biomed Co., Ltd. | 162.91 Million TWD | -592.719% |
Foresee Pharmaceuticals Co., Ltd. | -1.03 Billion TWD | 208.898% |
Handa Pharmaceuticals, Inc. | 726.88 Million TWD | -55.253% |
UniPharma Co., Ltd. | -21.81 Million TWD | 5273.562% |
Anxo Pharmaceutical Co., Ltd. | 21.86 Million TWD | -5062.202% |
Alar Pharmaceuticals Inc. | 382.61 Million TWD | -194.946% |
Winston Medical Supply Co., Ltd. | 158.75 Million TWD | -610.849% |
Mercury Biopharmaceutical Corporation | -43.81 Million TWD | 2675.564% |
Bioray Biotech Co., Ltd | -11.55 Million TWD | 9863.033% |
TSH Biopharm Corporation Limited | 61.98 Million TWD | -1720.499% |